Clover Health Investments, Corp. CLOV
4.69 USD +0.40 (+9.32%)
At closeNov 4, 2026, 6:28 PM EST
4.64 -0.05 -1.07%
After hours · Nov 4, 6:28 PM ET
4.40 Day range 4.78
1.58 52-week range 5.59
- YTD
- +99.57%
- 1 year
- +33.24%
Benzinga news
benzinga.com Clover Health Investments Raises FY2026 Sales Guidance from $2.920B-$3.000B to $2.970B-$3.000B vs $2.954B Est Clover Health Investments (NASDAQ:CLOV) raises FY2026 sales outlook from $2.920 billion-$3.000 billion to $2.970 billion-$3.000 billion vs $2.954 billion estimate.
benzinga.com Clover Health Investments Q3 EPS $0.01 Beats $(0.00) Estimate, Sales $759.304M Beat $738.423M Estimate Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.00) by Infinity percent. This is a 120 percent increase over…
benzinga.com This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday Analysts initiated coverage with Buy/Overweight ratings on KZIA ($27), PSQL ($12), NSRX ($7) and LGCY ($16).
benzinga.com This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
benzinga.com This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Analysts initiated coverage: Hold ALHC; Overweight/$6 SPRO; Buy/$3 LABT; Buy/$6 CLOV.
benzinga.com Needham Initiates Coverage On Clover Health Investments with Buy Rating, Announces Price Target of $6 Needham analyst Matthew Shea initiates coverage on Clover Health Investments (NASDAQ:CLOV) with a Buy rating and announces Price Target of $6.
benzinga.com QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
benzinga.com Clover Health Stock Pops: What's Happening? Clover Health Investments shares are jumping after CMS awarded the company's Medicare Advantage plans high 2027 Star ratings.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market session. The market value of their outstanding shares is at $46.4 billion. XORTX Therapeutics (NASDAQ:XRTX)…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thursday's after-market session. XORTX Therapeutics (NASDAQ:XRTX) stock increased by 22.7% to $2.27.…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.- benzinga.com UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5 UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $4.75 to $5.
benzinga.com Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On Thursday US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporting strong Q2 results & raised guidance.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
benzinga.com Clover Health Investments Raises FY2026 Sales Guidance from $2.810B-$2.920B to $2.920B-$3.000B vs $2.910B Est Clover Health Investments (NASDAQ:CLOV) raises FY2026 sales outlook from $2.810 billion-$2.920 billion to $2.920 billion-$3.000 billion vs $2.910 billion estimate.- benzinga.com Clover Health Investments Q2 EPS $0.05 Beats $0.03 Estimate, Sales $743.167M Beat $728.267M Estimate Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 350 percent increase over losses…
- benzinga.com Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $5.5 Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and raises the price target from $4.2 to $5.5.
benzinga.com Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 million in 2027 bonus payments.
benzinga.com Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to get in the crosshairs anymore."
benzinga.com Clover Health Investments' Clover Care Services CEO Brady Priest Stepping Down; Co. Integrating Its Home-Care Business With Its Broader Operations; Not Appointing Priest's Successor https://www.sec.gov/ix?doc=/Archives/edgar/data/1801170/000180117026000153/clov-20260615.htm- benzinga.com UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $4.75 UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $2.75 to $4.75.
benzinga.com Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating Clover Health shares are extending Wednesday's 18.9% surge after a court-ordered Medicare upgrade lifted its PPO plan to 4.5 Stars.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Caseys General Stores Upbeat Q4 Earnings, Joins Applied Optoelectronics, Clover Health Investments And Other Big Stocks Moving Higher On Wednesday US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% after beating earnings. Other big gainers incl. CBRL, PLBL, RXT, YB, AXTI, AAOI, LMND, CLOV, TGTX,…- benzinga.com Clover Health Announces That Its 2026 Star Rating Has Been Recalculated At 4.5 Following U.S. Court's Summary Judgement On June 9, 2026, CMS informed Clover that, consistent with the Court's order, it has recalculated Clover's 2026 Star Rating as 4.5 Stars, and has instructed Clover to submit alternate bids at 4.5…
benzinga.com Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $4.2 Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and raises the price target from $3.2 to $4.2.
benzinga.com Jim Cramer Won't Recommend Mortgage Stocks Because 'I Never Know What They Really Own' — But He Loves Intel's 'Burgeoning Packaging Division' Cramer criticizes Clover Health's quarterly results, recommends Amkor for semiconductor packaging, and expresses caution over mortgage stocks.
benzinga.com Lowe's, ZTO Express, Viavi Solutions And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session US stock futures higher, Lowe's shares fall after reporting earnings. Other stocks declining in pre-market trading. Photo via Shutterstock
benzinga.com Earnings Scheduled For May 6, 2026 - benzinga.com Clover Health Investments Affirms FY2026 Sales Guidance of $2.810B-$2.920B vs $2.878B Est Clover Health Investments (NASDAQ:CLOV) affirms FY2026 sales outlook from $2.810 billion-$2.920 billion to $2.810 billion-$2.920 billion vs $2.878 billion estimate.
benzinga.com Clover Health Investments Q1 EPS $0.05 Beats $0.03 Estimate, Sales $749.200M Beat $714.893M Estimate Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of…- benzinga.com Clover Health Investments CFO Peter Kuipers Steps Down, Effective March 30; Clay Thornton Appointed Interim Successor Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced…
- benzinga.com Canaccord Genuity Maintains Buy on Clover Health Investments, Lowers Price Target to $3.2 Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and lowers the price target from $3.7 to $3.2.
- benzinga.com Clover Health's Subsidiary Publishes Whitepaper on "Driving Clinical Excellence in Chronic Disease" Highlighting Use of Counterpart Assistant Associated With 18%–22% Fewer Flu-Related Acute Care Events Among COPD And CHF Patients Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), and a leading AI-powered…
- benzinga.com Clover Health Sees FY2026 Sales $2.810B-$2.920B vs $2.740B Est Full Year 2026 Guidance:Average Medicare Advantage membership of 154,000 - 158,000, representing 46% growth year-over-year at the midpointTotal revenues between $2.81 billion and $2.92 billion,…
benzinga.com Clover Health Investments Earnings Report: Q4 Overview - benzinga.com Clover Health Investments Q4 EPS $(0.10), Inline, Sales $487.707M Beat $467.056M Estimate Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 150 percent decrease over losses of $(0.04) per share from…
- benzinga.com Earnings Scheduled For February 26, 2026
benzinga.com Clover Health (CLOV) Slides As Trump Medicare Advantage Shock And UnitedHealth Earnings Hit Insurer Sentiment Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.
benzinga.com 'Trump Administration Proposes Keeping Steady the Rates Medicare Pays Insurers' - WSJ Exclusive https://www.wsj.com/health/healthcare/trump-administration-proposes-keeping-steady-the-rates-medicare-pays-insurers-34ca4e3a
benzinga.com Canaccord Genuity Maintains Buy on Clover Health Investments, Maintains $3.7 Price Target Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and maintains $3.7 price target.- benzinga.com 10 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November 
benzinga.com Clover Health Stock Is Climbing Wednesday: What's Going On? Clover Health Investments Corp (NASDAQ: CLOV) stock is rising Wednesday after the company announced that it expects to achieve its first full-year GAAP net income profitability this year.
benzinga.com TG Therapeutics, Clover Health Investments, Nutrien And Other Big Stocks Moving Higher On Wednesday - benzinga.com Clover Health Investments Reports 53% YOY Membership Growth In Its Medicare Advantage Plans For 2026 Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), today announced 53% year-over-year membership growth in its Medicare Advantage (MA) PPO plans for the…
- benzinga.com Politico Reported The White House To Propose A Two-year Extension Of Obamacare Subsidies With New Limits On Eligibility https://www.politico.com/newsletters/inside-congress/2025/11/24/trumps-obamacare-move-blindsides-conservatives-00666700
- benzinga.com Canaccord Genuity Maintains Buy on Clover Health Investments, Lowers Price Target to $3.7 Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and lowers the price target from $4.1 to $3.7.
benzinga.com Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session